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Peak Mean
Pc 42.6 ± 24.3 32.1 ± 16.1
Pi 64.0 ± 26.7* 38.4 ± 16.9*
Pr 47.9 ± 22.9* 29.9 ± 15.3
Pa 43.5 ± 23.7 27.7 ± 15.7t
Clinical Application of Three-dimensional
Echocardiographlc Laser Stereolithography:
Effect of Leaflet Funnel Geometry on the
Coefficient of Orifice Contraction In Mitral
Stenosis
Dan Gilon, Edward G. Cape, Mark D. Handschumacher. Lang Jiang, Charles Sears,
Joan Solheim, Eleanor Morris. John T. Strobel, Arthur E. Weyman, Robert
A. Levine. Massachusetts General Hospital, Boston. MA; Children's Hospital of
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increased by 82% (P < 0.05) in POL, but remained unchanged in VOL pa-
tients. Epinephrine was elevated by 65% (P < 0.05) in POL and 62% (P <
0.05) in VOL group. Dopamine was cyclic AMP were not altered. The results
show that in left heart valve disease. the sympathetic nervous system re-
sponds to POL by decreasing P-ADR activity as a result of elevated plasma
norepinephrine concentration. and to VOL by increasing a-ADR and reducing
P-ADR activity associated with an increase in epinephrine level.
Three-dimensional 130) echo reconstruction can potentially allow us to ad-
dress uniquely 3-dimensional questions of scientific interest: for example.
the effect of 3D leaflet geometry proximal to the limiting orifice of a stenotic
valve on the coefficient of orifice contraction (Cc) = the effective orifice area
(venacontracta)lthe anatomic area. This is important because: 1) for a given
flow rate and anatomic area. a lower Cc gives a higher maximal velocity,
pressure gradient, and possible head loss; and 2) Cc. assumed constant in
the Gorlin equation. may vary with valve shape (62% for a flat plate. 100%
for a long tube). To date. it has not been possible to study this effect with
the actual 3D shapes of valves in patients. We therefore used a spark gap
system with respiratory and ECG gating to reconstruct leaflet funnel geome-
tries typically seen in patients with mitral stenosis (MS) at maximal leaflet
opening: a mobile. doming valve and an immobile valve with a flatter conical
funnel. 3 models of each geometry were then constructed by stereolithog-
raphy (computerized laser polymerization), with orifice areas of 0.5. 1.0 and
1.5 cm2. Effective area (flow rate/continuous wave Doppler velocity) and Cc
were determined for flow rates producing velocities of 1-3 m/s.
Results: Cc varied minimally with flow rates. but prominantly with shape
(averages of flow rates follow):
The echocardiographic (E) aortic valve pressure gradient (Ll.P) is useful to
assess the severity of aortic stenosis. However, E Ll.P using the modified
Bernoulli equation (Pi) often exceeds that measured by catheter (Pc). Sub-
valvular acceleration and pressure recovery (Rp) need to be calculated to get
E Ll.P that more closely reflects Pc. To determine the contribution of each of
these components. a more complete descriptor of the Ll.P was developed us-
ing the complete Bernoulli equation and a formula for pressure recovery de-
veloped by Clark. This equation was applied to a published pediatric data set.
The pressure data (mmHg) are presented below (Pr = Ll.P corrected only for
Rp and Pa = Ll.P corrected for both Rp and subvalvular acceleration) (mean
± SO):
*p < 0.001, t p < 0.01 vs Pc
Peak E Ll.P corrected for both subvalvular acceleration and Rp reduced the
difference between E and cath Ll.P from -21.2 ± 14.5 to 0.6 ± 12.3 mmHg (p
< 0.001). The R-value increased from 0.84 to 0.87. and SEE decreased from
13.3 to 12.1 mmHg. Mean E AP corrected only for Rp reduced the difference
between echo and cath Ll.P from 6.3 ± 9.8 to -2.2 ± 8.3 mmHg (p < 0.001).
The R-value increased from 0.83 to 0.86, and SEE decreased from 9.2 to 8.2
mmHg.
We conclude: Rp and subvalvular acceleration contribute to overestima-
tion of E Ll.P seen in pediatric patients. Correction for both results in a peak
Ll.P more closely related to cath. Correcting only for Rp realized the best
correlation of mean E Ll.P with cath. This may be due to the subvalvular ac-
celeration having little effect on Ll.P at the beginning and end of ejection.
The Effects of Pressure Recovery and
Subvalvular Acceleration May Explain the
Discrepancy Between Catheterlsation and
Echocardlographlc Pressure Gradients in
Children with Aortic Valve Disease
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Normal %ABN MVP %ABN
marginal thickness (mm) 4.07 ± 044 3 5.32 ± 0.75* 59
annular diameter (mm) 26.9± 1.5 3 31.1 ± 2.3* 31
leaflet length (mm) 22.8 ± 2.0 1 25.7 ± 1.7** 26
chordal length (mm) 25.6 ± 2.7 3 26.0 ± 2.5** 7
Gender Associated Differences in Asymptomatic
Aortic Stenosis: Exercise Capacity, Functional
Status, and Diastolic Left Ventricular Filling
Malcolm E. Legget. Alan S. Pearlman. Nancy L. Healy, Carolyn Y. Miyake-Hull, Carol
D. Kraft, Catherine M. Otto. University of Washington, Seattle, WA
Male Female p value
Age Iyears) 60 ± 15 65 ± 19 NS
Functional status score (%) 95 ± 7 88 ± 14 0005
End-diastolic volume index (ml/m2) 48 ± 14 42 ± 15 0.09
End-systolic volume index (mllm2) 16 ± 7 14±6 NS
Ejection fraction (%) 67 ± 6 67 ± 10 NS
Evelocity time integral (em) 92±74 16.2 ± 7.6 0001
A velocity time integrallcm) 6.2 ± 5.1 10.0 ± 5.1 0005
Exercise treadmill duration (mins) 80 ± 3.9 4.5 ±4.1 0.001
Functional aerobic impairment (%) 2 ± 33 25 ± 48 0.02
Resting heart rate (bpm) 70 ± 15 75 ± 15 NS
Peak heart rate (bpm) 148 ± 29 141 ± 26 NS
Peak stroke volume index (ml/m2) 51 ± 15 47 ± 16 NS
Peak cardiac output II/min) 15.5 ± 59 11.4 ±4.0 0004
Peak cardiac index (I/min/m2) 7.7 ± 2.8 6.7 ± 2.7 NS
Change in cardiac index (1/min/m 2) 4.0 ± 2.1 3.2 ± 2.3 017
Effect of Left Ventricular Pressure and Volume
Overload on Adrenoceptor Activity in Patients
with Left Heart Valve Disease
Nduna Dzimiri. Mrinalini Kumar, Azadail Moorji, Ganga Prabhakar, Carlos
M.G. Duran. King Faisal Specialist Hospital and Research Centre. Riyadh, Saudi ArabIa
Conclusions: In AS patients without clinical symptoms. women have lower
exercise capacity and functional status than men even though measures of
LV function and AS severity are similar. Decreased augmentation of cardiac
output with exercise and altered diastolic filling patterns may explain these
findings.
Among MVP patients over 70% had at least one and 40% had at least
two structural abnormalities. In addition, MVP patients with significant mitral
regurgitation had increased leaflet thickness (p < 0.01) and annular diameter
(p ~ 0.0001) compared to patients without significant MR.
Conclusions: The majority of MVP patients have structural abnormalities
which can be defined echocardiographically. Structural abnormalities are
rarely seen in normal subjects. The assessment of leaflet thickness, annular
diameter, leaflet length and chordal length is fundamental to the definition
and stratification of patients with FMV
the parasternal long-axis view and mitral annular diameter from the apical
4-chamber view. Values 2SD above the normal mean were considered ab-
normal (%ABN).
Results:
In order to examine gender related differences in left ventricular geometry, di-
astolic filling. exercise capacity and functional status, 45 male and 24 female
subjects with asymptomatic aortic stenosis (AS) were evaluated with 20
and Doppler echocardiography before and immediately after Bruce protocol
treadmill exercise tests. Functional status was assessed by a standardized
questionnaire using a 0-100% scale. There was no difference in AS severity
between men and women (maximal AS jet velocity 3.5 ± 0.6 vs 3.6 ± 0.6
m/s. p ~ NS; aortic valve area index 0.7 ± 0.2 vs 0.6 ± 0.2 cm2/m2. p = NS).
A comparison of men and women is shown (mean values ± 1 SO):
*p 0.0001 vs normal, **p < 0.05 vs normal
We tested the hypothesis that the effect of left ventricular pressure over-
load (POL) on the sympathetic activity may be different from that of VOlume
overload (VOL) in patients (pts) with mitral and aortic valve disease. The a-
and p-adrenoceptor (ADR) activities were determined by radioligand binding
methods, plasma catecholamine levels by HPLC using and electrochemical
detector and cyclic AMP was evaluated by radioimmunoassay. Platelet a-
ADR density was elevated from 4.72 ± 0.41 fmol (control; n = 29) to 8.02
± 0.92 fmol per 107 cells (P < 0.001) in the VOL group (n = 25), but re-
mained unchanged at 5.01 ± 0.86 fmol per 107 cells in the POL Group (n
= 15). The lymphocyte p-ADR density was attenuated from 50.1 DO ± 9.5
fmol to 10.9 ± 2.7 fmol (P < 0.0001) in the POL group and up to 13.4 ±
2.6 fmol per 106 cells (P < 0.05) in the VOL group. There was no significant
change in either the a-adrenoceptor affinityto [3H-yohimbin binding orthat of
the p-ADR to [125I)-iodocyanopindolol binding. Plasma norepinephrine was
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feasible in 40 (83%) pts.
TIE TEE PI. CATH
MIG(mmH9) 55.9* 62.4
mGlmmHg) 41.8* 45.8
LVOT area Icm2) 39 4.0'
AVAlcm2) 0.91* 0.90*' 0.88* 0.89
Correlations between Doppler- and CATH-derived gradients were excellent
either simultaneously or not (MIG = 0.96, SEE = 6, p < 0.001; mG, r = 0.96,
SEE = 4, P < 0.001; AVA, r 0.92, SEE 0.18, P < 0.0011. PL-AVA and CATH
correlated less closely (r 0.78, SEE 0.22, P < 0.001). In conclusion: 1) TEE-
LVOT is measurable in 100% of AS pts and can be accurately used as an
alternative when TIE-LVOT is suboptimal; 2) AVA-PL is measurable in 83%
of AS pts and less accurate than the CE; and 3) Doppler-derived gradients
do not need to be done simultaneously to accurately reflect CATH as long
as Doppler is performed in dose temporal relation and by an experienced
sonographer.
*, comparison with CATH p < 0.001, t, comparison with TIE p < 0.001)
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Prognostic Value of Ultra-Low Frequency Heart
Rate Variability in Chronic Aortic Regurgitation
Lisa A. Freed, Kenneth M. Stein, Jeffrey S. Borer, Clare Hochreiter, PhylliS Supino,
Richard B. Devereux, Paul Kligfield. The New York Hospital- Cornell Medical Cenrer,
New York, NY
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(1) For any anatomic area, Cc was larger for the longer tapered dome,
which allows more gradual flow convergence proximal to the limiting ori-
fice (less distal contraction). (2) For each funnel shape, Cc increased with
increasing orifice to proximal funnel size (more tube-like). Conclusions: Cc,
which can alter net head loss, is importantly affected by the variations in
leaflet geometry seen in patients. Echo stereolithography can allow us to
address such uniquely 3D questions.
Effects of Facilitation on Human AV Nodal Fast
and Slow Pathways
Sotalol in the Treatment of Resistant
Supraventricular Arrhythmias
Paul E. Nolan, Frank I. Marcus, d,I-Sotalol Compassionate Use Investigators.
University ofArizona, Tucson, AZ
D,L-Sotalol is newly approved for the treatment of life-threatening ventricu-
lar arrhythmias. Several small studies suggest that d,l-sotalol is also useful in
the management of supraventricular arrhythmias (SVA). To determine the ef-
ficacy and safety of d,l-sotalol in the treatment of resistant SVA, data from the
d,l-sota/o/ compassionate use database were examined. One hundred fifty-
four patients, 53 ± 15.3 years of age with SVA, who had failed an average of
5.2 ± 1.8 antiarrhythmics, were enrolled. Ninety-four (61 %) patients had AF,
22 (14%) WPW, 20 (13%) SVT, 12 (8%) AFL and 6 (4%) AVNRI Forty-three
patients (28%1 had d,l-sotalol discontinued during the acute phase chiefly
due to lack of response (n = 23) or adverse effects (n = 15). One hundred
eleven patients (72%) entered into the long-term phase. After 6, 12, 18 and
27 months of treatment, the probability of no recurrence of SVA was 61 %,
54%, 51 % and 36%, respectively. Also at a mean duration of therapy with
d,l-sotalol of 8.7 months and compared to baseline. the percent of patients
having palpitations or dizziness decreased from 92% to 74% (p = 0.005) and
from 56% to 40% (p = 0.0231, respectively. During long-term treatment, 48
of 111 (43%) patients discontinued d,l-sota/ol chiefly because of loss of ef-
ficacy (n = 30) or adverse effects (n = 9). The probability of continuing with
d,l-sotalol at 6, 12, 18 and 27 months was 69%, 58%, 56% and 49%, respec-
tively. New clinical events attributable to d,l-sotalol were mostly cardiovas-
cular (palpitations, bradycardia, chest pain and dyspnea) or central nervous
effects (fatigue, dizziness and sleep problems). Only 4 (2.6%) of the 154 pa-
tients experienced proarrhythmia, of which 3 (1.9%) episodes were torsades
de pointes: 2 in the acute phase and 1 in the long-term phase. None of these
episodes were fatal.
Conclusion: Estimates of arrhythmia and symptom recurrence in addition
to safety data suggest that d,l-sotalol is efficacious in the treatment of drug-
refractory SVA.
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Role of Biplane Transesophageal
Echocardiography In Assessing Severity of Aortic
Stenosis: Planimetry vs. Continuity Equation
Miguel Zabalgoltia, Avanindra Jain, Rex Outtrim, Edward Sako, Robert A. O'Rourke.
The University of Texas Health Science Center at San Antonio, San Antonio, TX
Ultra-low frequency heart rate variability can predict progression to valve
surgery or cardiac death in patients with mitral regurgitation, but its prog-
nostic value in patients with chronic pure aortic regurgitation has not been
defined. We examined heart rate variability in 46 asymptomatic or minimally
symptomatic patients with chronic severe aortic regurgitation and no evi-
dent coronary disease, who underwent ambulatory electrocardiography as
part of a prospective study of the natural history of regurgitant valvular dis-
eases. At entry, all patients were in sinus rhythm, and were NYHA functional
class I or early II, with left ventricular ejection fraction :;:45%, left ventricular
dimension in diastole (LVIDd) :;:5.5 cm in females, LVIDd :;:5.9 cm in males.
Endpoints were progression to aortic valve replacement (n = 19) or cardiac
death (n = 1). A measure of ultra-low frequency heart rate variability, SDANN,
was calculated as the standard deviation of the 5 minute mean RR intervals
over 24 hours. Based on a median SDANN of 144 msec as a partition value,
event-free survival in patients with SDANN <144 msec (n = 23) was com-
pared to that in patients with SDANN :;:144 msec (n = 23) using the log rank
test, as shown in the figure. The average annual risk of endpoint events was
10.2% for SDANN <144 msec and 2.6% for SDANN :;:144 msec (p = 0.003).
Conclusion: Ultra-low frequency heart rate variability measured as SDANN
strongly concentrates risk of progression to valve surgery or cardiac death
in asymptomatic and minimally symptomatic patients with chronic pure aor-
tic regurgitation.
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Accurate calculation of aortic valve area (AVA) by the continuity equation
(CE): A1 . Vl N2' relies on an optimal 2D imaging of Al (LV outflow tract
[LVOTI diameter/2 . 1r. To evaluate: 1) whether transesophageal echo (TIE)-
LVOT can be utilized as an alternative to transthoracic echo (TIE), and 2) to
compare the AVA measured by direct TEE planimetry (PL) in the same popu-
lation, 48 pts with suspected aortic stenosis (AS) underwent TIE simultane-
ously (24 pts) or within 7 days (24 pts) prior to catheterization (CATH). When
simultaneously, Doppler signals were superimposed to CATH pressure trac-
ings. Biplane TEE was done within 48-hrs of CATH. AVA by PL, Doppler-
derived maximal instantaneous gradient (MIG), mean gradient (mG) and AVA
using LVOT area from TTE and from TEE were compared with CATH. Results:
TTE-LVOTwas suboptimal in 9 (19%) pts, and in none byTEE. AVA by PL was
Gregory A. Kidwell, Gerard J. Fahy. The Cleveland Clinic Foundation, Cleveland, Ohio
The effect of facilitation on AV nodal function was studied in twelve patients
before and after radiofrequency ablation (RFA) of the slow pathway. AV nodal
recovery time (H 1A2 or H2A3) was plotted against AV nodal conduction time(A2H2 or A3H3) for test intervals from control and facilitation protocols re-
spectively (see figure). The mean Al A2 for the facilitation protocol was 363 ±
15 ms. The minimal recovery time (RT), functional refractory period (FRP) and
conduction time (CT) of both the fast and slow pathways were determined.
The effect of facilitation on CT was assessed at the minimal RT obtained
during control testing. Results:
